Search

Monica E. Millner

Examiner (ID: 17239, Phone: (571)270-7507 , Office: P/3632 )

Most Active Art Unit
3632
Art Unit(s)
3632, 3508, 3627
Total Applications
1497
Issued Applications
1151
Pending Applications
94
Abandoned Applications
283

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17104290 [patent_doc_number] => 11124485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-21 [patent_title] => Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage [patent_app_type] => utility [patent_app_number] => 16/773411 [patent_app_country] => US [patent_app_date] => 2020-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30035 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 490 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773411 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/773411
Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage Jan 26, 2020 Issued
Array ( [id] => 15930961 [patent_doc_number] => 20200157114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => OPTICALLY ACTIVE AZABICYCLO RING DERIVATIVE [patent_app_type] => utility [patent_app_number] => 16/748191 [patent_app_country] => US [patent_app_date] => 2020-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28275 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16748191 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/748191
Optically active azabicyclo ring derivative Jan 20, 2020 Issued
Array ( [id] => 17407132 [patent_doc_number] => 11248001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-15 [patent_title] => PCSK9 inhibitors and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/744929 [patent_app_country] => US [patent_app_date] => 2020-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69319 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744929 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/744929
PCSK9 inhibitors and methods of use thereof Jan 15, 2020 Issued
Array ( [id] => 18237576 [patent_doc_number] => 20230069886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => AROMATIC SULPHONAMIDES DERIVATIVES THAT INHIBITS PDI A3, THEIR SYNTHESIS AND USE [patent_app_type] => utility [patent_app_number] => 17/791657 [patent_app_country] => US [patent_app_date] => 2020-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16206 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17791657 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/791657
AROMATIC SULPHONAMIDES DERIVATIVES THAT INHIBITS PDI A3, THEIR SYNTHESIS AND USE Jan 9, 2020 Pending
Array ( [id] => 16948028 [patent_doc_number] => 20210206719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => AMINO ALCOHOL-BORON-BINOL COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE AMINO ALCOHOL DERIVATIVE BY USING SAME [patent_app_type] => utility [patent_app_number] => 16/740083 [patent_app_country] => US [patent_app_date] => 2020-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 389 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16740083 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/740083
Amino alcohol-boron-binol complex and method for preparing optically active amino alcohol derivative by using same Jan 9, 2020 Issued
Array ( [id] => 16962839 [patent_doc_number] => 20210214338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => 1,3-DIPOLAR CYCLOADDITIONS, AND STAUDINGER LIGATIONS FOR CONJUGATING BIOMOLECULES USING CLICK CHEMISTRY [patent_app_type] => utility [patent_app_number] => 16/740153 [patent_app_country] => US [patent_app_date] => 2020-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21598 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16740153 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/740153
1,3-dipolar cycloadditions, and Staudinger ligations for conjugating biomolecules using click chemistry Jan 9, 2020 Issued
Array ( [id] => 16735810 [patent_doc_number] => 10961447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-30 [patent_title] => Light emitting material, manufacture method thereof and organic light emitting diode using the light emitting material [patent_app_type] => utility [patent_app_number] => 16/737913 [patent_app_country] => US [patent_app_date] => 2020-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3889 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737913 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/737913
Light emitting material, manufacture method thereof and organic light emitting diode using the light emitting material Jan 8, 2020 Issued
Array ( [id] => 17697067 [patent_doc_number] => 11370777 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-28 [patent_title] => Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same [patent_app_type] => utility [patent_app_number] => 16/737739 [patent_app_country] => US [patent_app_date] => 2020-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 171 [patent_no_of_words] => 98884 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737739 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/737739
Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same Jan 7, 2020 Issued
Array ( [id] => 16120589 [patent_doc_number] => 20200212317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-02 [patent_title] => P-TYPE ORGANIC SEMICONDUCTOR, COMPOSITION, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION DEVICE, AND IMAGE SENSOR [patent_app_type] => utility [patent_app_number] => 16/726416 [patent_app_country] => US [patent_app_date] => 2019-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6231 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16726416 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/726416
P-type organic semiconductor, composition, photoelectric conversion film, photoelectric conversion device, and image sensor Dec 23, 2019 Issued
Array ( [id] => 16086809 [patent_doc_number] => 20200197391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/723438 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79121 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16723438 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/723438
COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF Dec 19, 2019 Abandoned
Array ( [id] => 15800051 [patent_doc_number] => 20200123168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-23 [patent_title] => MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOF [patent_app_type] => utility [patent_app_number] => 16/721631 [patent_app_country] => US [patent_app_date] => 2019-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30833 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721631 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/721631
Morphic forms of G1T38 and methods of manufacture thereof Dec 18, 2019 Issued
Array ( [id] => 17497551 [patent_doc_number] => 11286243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-29 [patent_title] => Ferroportin inhibitors and methods of use [patent_app_type] => utility [patent_app_number] => 16/712628 [patent_app_country] => US [patent_app_date] => 2019-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52878 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 369 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712628 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/712628
Ferroportin inhibitors and methods of use Dec 11, 2019 Issued
Array ( [id] => 15740481 [patent_doc_number] => 20200109128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-09 [patent_title] => PYRAZINE COMPOUND [patent_app_type] => utility [patent_app_number] => 16/710035 [patent_app_country] => US [patent_app_date] => 2019-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51797 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710035 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/710035
Pyrazine compound Dec 10, 2019 Issued
Array ( [id] => 15768705 [patent_doc_number] => 20200115370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => SELECTIVE NR2B ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 16/707382 [patent_app_country] => US [patent_app_date] => 2019-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16707382 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/707382
Selective NR2B antagonists Dec 8, 2019 Issued
Array ( [id] => 17044862 [patent_doc_number] => 11098030 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-24 [patent_title] => EGFR inhibitor compounds [patent_app_type] => utility [patent_app_number] => 16/703544 [patent_app_country] => US [patent_app_date] => 2019-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22702 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16703544 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/703544
EGFR inhibitor compounds Dec 3, 2019 Issued
Array ( [id] => 18801265 [patent_doc_number] => 11834416 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-05 [patent_title] => Cleavable agents [patent_app_type] => utility [patent_app_number] => 16/698332 [patent_app_country] => US [patent_app_date] => 2019-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 5195 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16698332 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/698332
Cleavable agents Nov 26, 2019 Issued
Array ( [id] => 16853359 [patent_doc_number] => 20210154104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => SUBSTANCES AND METHODS FOR BEDSIDE MANAGEMENT OF POST-OPERATIVE PAIN [patent_app_type] => utility [patent_app_number] => 16/693232 [patent_app_country] => US [patent_app_date] => 2019-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3334 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16693232 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/693232
SUBSTANCES AND METHODS FOR BEDSIDE MANAGEMENT OF POST-OPERATIVE PAIN Nov 22, 2019 Abandoned
Array ( [id] => 17520440 [patent_doc_number] => 20220106289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => NLRP3 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/296151 [patent_app_country] => US [patent_app_date] => 2019-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296151 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/296151
NLRP3 INHIBITORS Nov 21, 2019 Abandoned
Array ( [id] => 16398707 [patent_doc_number] => 20200339565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-29 [patent_title] => PRODRUG SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE [patent_app_type] => utility [patent_app_number] => 16/684870 [patent_app_country] => US [patent_app_date] => 2019-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 149530 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16684870 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/684870
PRODRUG SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE Nov 14, 2019 Abandoned
Array ( [id] => 17756218 [patent_doc_number] => 11396502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-26 [patent_title] => Substituted heterocyclic derivatives as PI3K inhibitors [patent_app_type] => utility [patent_app_number] => 16/681267 [patent_app_country] => US [patent_app_date] => 2019-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60775 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 4585 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16681267 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/681267
Substituted heterocyclic derivatives as PI3K inhibitors Nov 11, 2019 Issued
Menu